Search

everythinglearnresearchcommunity

for

Search:↓

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Researchers made new compounds that could potentially be developed into anticancer drugs.

Paclitaxel chemotherapy causes premature aging and damage to hair follicles, potentially leading to permanent hair loss.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Improving hair health and managing conditions can enhance scalp cooling effectiveness in preventing hair loss during chemotherapy.

Intralesional cidofovir may be a viable alternative treatment for SCC.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Personalized hair care strategies are needed for Black cancer patients to prevent hair loss during chemotherapy.

Financial support and better counseling are needed to make chemotherapy more affordable and manageable for women in Pakistan.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

A lotion with natural extracts significantly sped up hair growth in women with hair loss from chemotherapy.

A woman with scalp lymphoma and hair loss improved with radiotherapy, highlighting the need for biopsies in similar cases.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Imatinib can cause hair loss due to lichen planopilaris.

Nab-paclitaxel chemotherapy can rarely cause lupus-like skin issues.

FOL-005, a new substance, was found to reduce hair growth without toxicity when injected into skin, suggesting it could be used to treat excessive hair growth.

A botanical extract may help manage hair loss from chemotherapy by preventing cell death in hair follicles.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Cyclosporine effectively treated a woman's stubborn skin condition.

Suppressing eIF4E can prevent hair loss from chemotherapy.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Chemotherapy for leukemia led to full hair regrowth in a child with alopecia totalis.

Certain cancer drugs can cause skin issues like rashes and itching.

Selumetinib significantly reduced tumor size and improved vision in a child with neurofibromatosis type 1.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.